Newsroom

In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some of the news content posted here.

by Neoteryx, on March 25,2021

According to a March 12, 2021 article by Adam Bonislawski in Genomeweb, researchers at Stanford University are profiling responses to the COVID-19 vaccinations. The Stanford study investigates the effects of …

Read Story
Topics:

by Neoteryx, on March 17,2021

AUCKLAND, NEW ZEALAND – March 2021 – New Zealand has proved to be one of the most successful nations in responding effectively to the coronavirus pandemic and controlling the spread …

Read Story
Topics:

by Neoteryx, on February 5,2021

LONDON — February 2021 — A home specimen collection service launched in late 2020 by Guy's and St Thomas, an NHS Foundation Trust hospital in London, is designed to keep …

Read Story
Topics:

by Neoteryx, on January 4,2021

Mitra Microsamples Help NIH Measure SARS-CoV-2 Raised Antibodies With 99-100% Accuracy LOS ANGELES / BETHESDA, MD — JANUARY 4, 2021 — After launching a “serosurvey” to track undetected cases of …

Read Story

by Neoteryx, on December 14,2020

December 2020 — At-Home Specimen Collection Is Vital to Socially Distant Testing; Multiple Labs Pivot to Process Remote Blood Samples Using Neoteryx’s Mitra® Microsampling Devices & Kits. The Coronavirus Pandemic …

Read Story
Topics:

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news